Lord, Abbett & Co
LUNG icon

Lord, Abbett & Co’s Pulmonx LUNG Stock Holding History

Lord, Abbett & Co’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-365,518
Closed -$4.66M – 572
2023
Q4 		$4.66M Buy
+365,518
New +$3.81M 0.02% 468
2022
Q4 		– Sell
-303,680
Closed -$5.06M – 612
2022
Q3 		$5.06M Buy
303,680
+124,326
+69% +$2.29M 0.02% 476
2022
Q2 		$2.64M Buy
179,354
+12,078
+7% +$249K 0.01% 529
2022
Q1 		$4.15M Sell
167,276
-154,387
-48% -$3.99M 0.01% 567
2021
Q4 		$10.3M Sell
321,663
-3,904
-1% -$143K 0.02% 480
2021
Q3 		$11.7M Buy
325,567
+124,157
+62% +$4.89M 0.03% 504
2021
Q2 		$8.89M Sell
201,410
-20,726
-9% -$902K 0.02% 547
2021
Q1 		$10.2M Buy
222,136
+25,023
+13% +$1.44M 0.03% 520
2020
Q4 		$13.6M Buy
+197,113
New +$9.65M 0.04% 479

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lord, Abbett & Co's LUNG Position: Q1 2024 in Review

Lord, Abbett & Co sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 365,518 shares — an estimated $4.66M sold.

Lord, Abbett & Co first reported a position in LUNG in Q4 2020 and held it in 9 quarters. The position peaked at $13.6M in Q4 2020. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • Lord, Abbett & Co reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 365,518 Pulmonx shares in Q1 2024, an estimated $4.66M.
  • Lord, Abbett & Co first reported a position in Pulmonx in Q4 2020 and held it in 9 quarters.
  • Lord, Abbett & Co's Pulmonx position peaked at $13.6M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on Lord, Abbett & Co's 13F filing for Q1 2024, filed 9 May 2024.